OptiBiotix raises £1m in new placing
5th Feb 2016 09:55
(ShareCast News) - OptiBiotix had an additional £1m to play with on Friday, announcing a new placing of 1,282,051 ordinary shares at 78p each. The AIM-traded life sciences company, which specialises in products treating obesity, high cholesterol and diabetes, said the placing shares were issued to f
Read moreSunday share tips: Britvic, Tungsten, Optibiotix
19th Jul 2015 17:49
(ShareCast News) - Shares in drinks maker and Wimbledon tennis sponsor Britvic are worth buying ahead of its third-quarter trading statement next Thursday, advised Questor in the Sunday Telegraph. The sunny weather in the UK and France should boost performance in the period, with analysts expecting
Read moreOptibiotex Health signs contract with Spanish research centre
9th Jul 2015 11:45
OptiBiotix Health, a life sciences business developing compounds to tackle obesity, has partnered with a research centre in Madrid to develop its technology platform. The company signed an agreement with the Instituto de Química Orgánica General, part of the Spanish National Research Council, which
Read moreOptiBiotex Health wins first contract for its cholesterol reducing product
2nd Jun 2015 11:15
Life sciences group OptiBiotix Health won a contract with a multinational consumer goods company to provide an option agreement for its cholesterol reducing product. The company did not disclose the name of the partner or any financial details as the terms of the agreement are confidential. OptiBio
Read more